ROC performance in life sciences and health care worldwide in 2011 and 2017

Published by
Matej Mikulic,
Feb 4, 2022
Between 2011 and 2017, the return on capital (ROC) for life sciences manufacturers decreased from 16.6 percent to 11.9 for pharmaceutical companies and from 13.8 percent to 9.9 percent for medtech companies. This statistic shows the return on capital performance in life sciences and health care worldwide in 2011 and 2017.

Return on capital performance in life sciences and health care worldwide in 2011 and 2017

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2020

Region

Worldwide

Survey time period

2011 and 2017

Citation formats
Use Statista now: Unlimited Access to All Statistics! $199 USD / Month
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharma and biotech M&A activity "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharma and biotech M&A activity

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

XR in healthcareMedical technologyAugmented reality (AR) in EuropeVirtual reality (VR)Augmented reality (AR)
All features, all contents, at all times: Learn more about our professional solutions.
Learn more about how Statista can support your business.
Menu